Page last updated: 2024-10-28

lidocaine and Thyrotoxicosis

lidocaine has been researched along with Thyrotoxicosis in 1 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Thyrotoxicosis: A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamakawa, M1
Sunagawa, M1
Shimabukuro, M1
Higa, N1
Takasu, N1
Kosugi, T1

Other Studies

1 other study available for lidocaine and Thyrotoxicosis

ArticleYear
Effect of sodium channel blocker, pilsicainide hydrochloride, on net inward current of atrial myocytes in thyroid hormone toxicosis rats.
    Thyroid : official journal of the American Thyroid Association, 2005, Volume: 15, Issue:7

    Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Electrocardiography; Heart Atria; Lidocaine; Male;

2005